UWMC booked a roughly $600 million Q2 hedging loss tied to TWO months after the deal collapsed, contributing to an expensive capital raise.
S Yet Another Value Blog Aug 11 11 clicks
CBIZ activist Ryan Bunn urges ending buybacks, issuing equity and resuming bolt-on acquisitions to delever after the $2.3 billion Marcum…
YT Yet Another Value Podcast Jul 14 2 clicks
VEON’s 84% Kyivstar stake and JazzCash underpin a sum-of-the-parts case for 4x upside, despite its sanctioned shareholder, capital…
S Yet Another Value Blog Jul 1 1 click
Wingstop generates most of its $697 million revenue from franchise royalties across a 3,153-restaurant, 98%-franchised system while…
S Bearhold Research Jun 28 2 clicks
A software powerhouse posts a record quarter while trading at a 52-week low, raising a valuation disconnect between its business model and…
S The Value Road Jun 12 5 clicks
Vidrala has grown from a Spanish glass-container maker into a multi-country packaging platform with expanding Latin American exposure.
S smallvalue. May 19 6 clicks
AXT’s 85.5%-owned Tongmei depends on offshore pricing, export approvals and transfer-pricing economics despite AI-optics demand.
S Maius Partners Apr 2 7 clicks
Shift4 built its payments business by acquiring gateway nodes and migrating merchants to its processing platform; revenue has compounded…
S Speedwell Memos Feb 19 1 click
A former value-investor darling, down 50%, pairs a monopoly with a recurring-revenue razor-and-blade business; debt paydown, margin…
S Treasure Hunting Feb 5 3 clicks
Haw Par combines Tiger Balm’s stable cash flows with property, leisure and healthcare operations plus stakes in UOB and UOL.
S smallvalue. Dec 17 4 clicks
SLS · short SELLAS Life Sciences Group faces a short case arguing that even a strong clinical outcome does not support its current valuation.
BL Value Investors Club May 25
Energy Fuels produces uranium and separated rare earth elements at its White Mesa Mill, with NdPr output since April 2024 and a domestic…
SA Joseph L. Shaefer Aug 22 1 click National Beverage’s rare share repurchase is framed as a buy signal, with 50% upside projected.
S Nat Stewart - Stock Picking Newsletter Nov 25 3 clicks
Argentine banks, tariff-exposed stocks and Customer’s Bancorp anchor an earnings-season watchlist after Milei’s election victory,…
S Cluseau Research Oct 27 3 clicks
Upstart says longer repayment terms lifted Q1 debt-settlement acceptances 50%, but does not disclose delinquency changes or the number of…
S John Hempton's Newsletter May 6 2 clicks
Sarepta’s Exondys 51 approval despite a 12-patient trial frames FDA regulatory risk and a call to remove Commissioner Robert Califf.
S John Hempton's Newsletter Oct 31 1 click